Biofrontera Inc. (NASDAQ:BFRI) went up by 22.03% from its latest closing price compared to the recent 1-year high of $14.63. The company’s stock price has collected -9.54% of loss in the last five trading sessions. Press Release reported 13 hours ago that Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
Is It Worth Investing in Biofrontera Inc. (NASDAQ :BFRI) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Biofrontera Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $11.00, which is $9.24 above the current price. BFRI currently public float of 3.60M and currently shorts hold a 46.68% ratio of that float. Today, the average trading volume of BFRI was 21.63M shares.
BFRI’s Market Performance
The volatility ratio for the week stands at 19.98% while the volatility levels for the past 30 days are set at 26.38% for Biofrontera Inc.. The simple moving average for the period of the last 20 days is -18.72% for BFRI stocks with a simple moving average of 13.38% for the last 200 days.
BFRI Trading at 13.38% from the 50-Day Moving Average
After a stumble in the market that brought BFRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.21% of loss for the given period.
Volatility was left at 26.38%, however, over the last 30 days, the volatility rate increased by 19.98%, as shares surge +16.57% for the moving average over the last 20 days.
During the last 5 trading sessions, BFRI fell by -9.54%, in comparison to the 20-day moving average, which settled at $7.75. In addition, Biofrontera Inc. saw -16.76% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BFRI
Current profitability levels for the company are sitting at:
- -44.21 for the present operating margin
- +48.92 for the gross margin
The net margin for Biofrontera Inc. stands at -58.29. The total capital return value is set at -120.36, while invested capital returns managed to touch -158.67.
The receivables turnover for the company is 4.67 and the total asset turnover is 0.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.43.